Cue Biopharma CSO Anish Suri's 2019 pay jumps 42% to $4.6M
Cue Biopharma reports 2019 executive compensation
By ExecPay News
Published: May 29, 2020
Cue Biopharma reported fiscal year 2019 executive compensation information on May 29, 2020.
In 2019, four executives at Cue Biopharma received on average a compensation package of $1.7M, a 17% increase compared to previous year.
Average pay of disclosed executives at Cue Biopharma
Anish Suri, Chief Scientific Officer, received $4.6M in total, which increased by 42% compared to 2018. 67% of Suri's compensation, or $3.1M, was in option awards. Suri also received $377K in bonus, $366K in salary, $753K in stock awards, as well as $4.1K in other compensation.
Daniel R. Passeri, Chief Executive Officer, received a compensation package of $1.2M, which increased by 44% compared to previous year. 51% of the compensation package, or $610K, was in option awards.
Colin Sandercock, General Counsel, earned $626K in 2019, a 89% increase compared to previous year.
Kerri-Ann Millar, Chief Financial Officer, received $448K in 2019.
Related executives
You may also like
Source: SEC filing on May 29, 2020.